 | • レポートコード：D0-MOR-AP0364 • 出版社/出版日：Mordor Intelligence / 2020年4月20日 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：健康管理 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、脳波検査システム/デバイスの世界市場について調査・分析した資料で、脳波検査システム/デバイスの市場概要、動向、セグメント別市場規模、地域別分析、競争状況、企業情報、市場機会分析などで構成されています。 |
The Electroencephalography Systems Devices Market is expected to register a CAGR of 8% during the forecast period. This is attributing to an increasing number of neurological disorders with increasing awareness about the same. Electroencephalography is the only clinical diagnostic instrument that has the ability to see the brain activity and reflects cortical neuronal functioning in Alzheimer patients. Moreover, high incidences of Alzheimer’s epilepsy, multiple sclerosis, dementia, Parkinson diseases, and stroke are the key driving factor for adopting this electroencephalography and this further trigger the market. As Per the Alzheimer’s Association, an estimate of 5.7 million populations in 2018 was suffered from Alzheimer’s results in boosting the market for diagnosing and monitoring purposes. Moreover, increasing product launches and product development is also promoting the growth of the market. For instance, in 2019, Nihon kohden, has launched VitalEEG wireless electroencephalogram devices for the assessment of brain wave information.
Key Market Trends
Standalone Electroencephalography System is Expected to Witness a Healthy Growth in Future
Standalone system is expected to witness healthy growth in future owing to an increasing number of neurological disorders such as tumors, strokes, cerebral palsy and other brain-related disorders. These target populations are more prone to admit in hospitals wherein these systems are commonly used. A standalone system is fixed at a particular place consist of hardware and software and is widely used in hospitals. This system allows doctors and physicians to interpret the results efficiently and high application in critical care is boosting the segment growth.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America expected to hold a major market share in the global Electroencephalography Systems Devices Market due to increasing incidences of neurological disorders, rising prevalence of sleep disorders. As per the ALS Association, around 5000 Americans diagnosed with Amyotrophic Lateral Sclerosis every year in the United States. In addition, as per Centers for disease control and prevention (CDC), Stroke is a leading cause of mortality in this region which results in the rising prevalence of diseases and further require continuous monitoring wherein these devices are widely adopted and hence propel the market in this region. Furthermore, increasing healthcare expenditure and the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.
Competitive Landscape
The Electroencephalography Systems Devices Market is fragmented competitive and consists of several major players. Some of the companies which are currently dominating the market are Natus Medical, Inc., Cadwell Industries, Inc., Medtronic, Nihon Kohden Corporation.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising R&D Expenditure
4.2.2 Increasing Prevalence of Neurological Disorders
4.2.3 Increasing Product Development and Launch
4.3 Market Restraints
4.3.1 Limitation of Electroencephalography System
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Portable Device
5.1.2 Standalone Device
5.2 By End User
5.2.1 Hospitals
5.2.2 Diagnostic Centers
5.2.3 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Natus Medical, Inc.
6.1.2 NeuroWave Systems, Inc
6.1.3 Cadwell Industries, Inc.
6.1.4 Medtronic
6.1.5 Nihon Kohden Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS